← Back to headlines
Big Pharma M&A Outpaces Biotech IPOs, JPMorgan Says
JPMorgan bankers report that mergers and acquisitions in the pharmaceutical sector continue to outpace initial public offerings in the biotechnology industry.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
